1. New and Evolving Concepts in Cardiovascular Disease Prevention and Management Nathan D. Wong, PhD, FACC Professor and Director Heart Disease Prevention Program University…

Slide 1Workshop 4: Il late-presenter Moderatori: G. Ippolito, M. Moroni Discussant: R. Iardino Risposta virologico-clinica e scelta della terapia C. Mussini Slide 2 760 pazienti/…

Slide 1Preliminary deliberations towards estimating the burden of HIV disease in children, in the light of need for ART Marie-Louise Newell, Kirsty Little, Madeleine Bunders…

Slide 1Modelling complex communities – measuring what matters? Jim Bown, Janine Illian and John Crawford University of Abertay Dundee [email protected] Slide 2 The soil…

Slide 1, Slide 2 Slide 3 What is an Insurance Policy? A contract with an insurance company that spells out what losses are covered, what the policy costs, and who receives…

Slide 1Incremental Reduction in Risk of Death Associated with Use of Guideline- Recommended Therapies in Patients with Heart Failure: A Nested Case Control Analysis of IMPROVE…

Slide 1MANAGING CONGESTIVE HEART FAILURE Annual Conference of the Lebanese Society of Family Medicine Antoine Sarkis, MD Associate Professor of Cardiology Hotel Dieu de France…

1. Population Biology: IB TOPIC 5.31 2. Biotic Potential• Biotic potential refers to unrestrained biologicalreproduction. Biological organisms can produceenormous numbers…

1. WHO, WHAT, WHEN, WHY & HOW GASB 43 & 45 2. Topics to be covered Who is GASB? What are GASB 43 & 45? When do we have to comply with the statements? Why were…

1. Health EconomicsLecture 5Cost and BenefitEvaluation Methods 2. RationalNever intentionallychoose to be worseoff 3. ChoicesWhat is life worth?How do we measure?Costs and…